L-733,060

Chemical compound
| L-733,060
| |
|---|---|
| Chemical nomenclature | |
| IUPAC name | (2S,3S)-N-[(1R,2R)-2-(3,4-Dichlorophenyl)-1-(1H-imidazol-4-yl)ethyl]-2-(2,4-difluorophenyl)-3-methoxy-3-(morpholin-4-yl)propanamide
|
| Identifiers | |
| CAS Number | 161715-24-8 |
| PubChem | 3083531
|
| ChemSpider | 2341451
|
| ChEMBL | 125 |
| Chemical data
| |
| Chemical formula | C24H25N3O3Cl2F2
|
L-733,060 is a chemical compound that acts as a potent and selective antagonist for the neurokinin 1 receptor (NK1 receptor). It is primarily used in scientific research to study the role of substance P and the NK1 receptor in various physiological and pathological processes.
Pharmacology[edit]
L-733,060 binds to the NK1 receptor, inhibiting the action of substance P, a neuropeptide involved in processes such as pain, inflammation, and emesis. By blocking this receptor, L-733,060 can help elucidate the role of substance P in these processes and has potential therapeutic implications for conditions like chronic pain, depression, and chemotherapy-induced nausea and vomiting.
Research Applications[edit]
L-733,060 is widely used in preclinical studies to investigate the function of the NK1 receptor. It has been instrumental in advancing our understanding of the pathophysiology of various conditions, including anxiety disorders, depression, and inflammatory diseases. Researchers utilize this compound to explore new therapeutic targets and develop novel treatments.
Chemical Properties[edit]
L-733,060 has a complex chemical structure characterized by multiple functional groups, including dichlorophenyl, difluorophenyl, and morpholinyl moieties. Its molecular formula is C24H25Cl2F2N3O3, and it has a molecular weight of 528.38 g/mol.
See Also[edit]
References[edit]
External Links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian